Philippe Archinard who is Chairman of the Board and Chief Executive Officer, Transgene, will be promoted to Chief Operating Officer, Technological Innovation and Scientific Partnerships on Jan. 1, 2021 (news posted on September 17 2020).
Philippe Sans who is Chief Executive Officer, Merieux NutriSciences, will be promoted to Chief Operating Officer, Strategy and Planning on Oct. 1, 2020 (news posted on September 17 2020).
Create an alert
to follow the executive moves at BioMerieux.
Tilray and Aphria have announced they will merge (posted on Dec 17, 2020).
AstraZeneca has announced the acquisition of Alexion Pharmaceuticals (posted on Dec 14, 2020).
Bristol-Myers Squibb has acquired MyoKardia (posted on Nov 18, 2020).
BioMerieux has 4 subsidiaries including Astute Medical, BioMerieux Americas and BioMerieux Germany. BioMerieux has 2,034 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Roche (Switzerland). BioMerieux is owned by Institut Merieux.
Learn about your clients' org charts. Understand their industries and their competitors.
View the executives' biographies. Contact the executives through our email platform.
Select key words to follow your clients. Receive alerts when executive movements happen.
File your clients in folders. Add private notes. Download our data in Excel on your PC.